NAD Refers Advertising for Star Herbs’ ‘My Low Press’ to FTC for Further Review

New York, NY – March 5, 2013 – The National Advertising Division has referred advertising for “My Low Press,” a dietary supplement marketed by Star Herbs, LLC, to the Federal Trade Commission for further review, after the company declined to participate in a NAD review of its advertising claims.

NAD is an investigative unit of the advertising industry’s system of self-regulation. It is administered by the Council of Better Business Bureaus.
As part of NAD’s initiative with the Council for Responsible Nutrition
to expand the review of advertising for dietary supplements, CRN challenged the following claims:

  •  “If your blood pressure remains high regardless of positive lifestyle changes, you’re likely to be prescribed medication. These treat only the symptoms rather than the core causes. And they can introduce serious undesired side effects. Star Herbs’ My Low Press herbal formula offers powerful, all-natural support for lowering blood pressure and maintaining it at normal levels without any side effects.”
  •  “And if you are at risk of hypertension, My Low Press may also help prevent its development.”
  •  “The My Low Press blend of natural herbs helps improve circulation throughout the different organs and reduces inflammation.”
  •  “My Low Press also helps alleviate blood related deficiencies such as anemia and dizziness.”
  •  “Star Herbs offers affordable natural solutions as alternatives to regular medications that are not only good for your body, but don’t cause the adverse side effects commonly associated with many pharmaceuticals.”
  •  “We provide natural supplements made from natural herbs and spices that can have an immediate impact on your symptoms and in the long term help balance your body for improved all-around health. Today most people are actively looking for alternative choices because many doctor-prescribed drugs introduce unnecessary health risks that are just as dangerous, if not more so, than the condition they are meant to treat.”
  •  “The natural supplements at Star Herbs offer alternative and long term remedies for conditions such as: high blood pressure, allergies, breath problems, kidney/liver problems.”
  •  “When I was first diagnosed with hypertension, my blood pressure numbers were persistently in the high 160s over 100. After taking the medication that was prescribed by my doctor, the numbers were normal but my entire body felt swollen and uncomfortable, so I decided to seek treatment with natural alternative medicine and that’s how I found Star Herbs’ My Low Press.
  •  After taking the all herbal, all natural formula My Low Press, my blood pressure has returned to normal; 130s over 80s, my feet, legs and all of my body are no longer puffy. Also the dizziness is gone… no more ringing in my ears, and I also sleep better at night now.
  •  I’m so happy with what My Low Press has done for me and NO side effects.”

NAD was extremely concerned that the challenged claims have the potential to influence consumers to forego necessary medical treatment for high blood pressure or hypertension, which could lead to serious health consequences for consumers.

However, the advertiser chose not to participate in this NAD proceeding. Pursuant to Section 2.10 of the NAD/NARB Procedures, NAD is referring this matter to the Federal Trade Commission.

 

Subscribe to the Ad Law Insights or Privacy Initiatives newsletters for an exclusive monthly analysis and insider perspectives on the latest trends and case decisions in advertising law and data privacy.

 

 

 

 

Latest Decisions

Decision

Direct Selling Self-Regulatory Council Recommends Lemongrass Discontinue Certain Earnings and Health-Related Product Claims

McLean, VA – May 6, 2024 – The Direct Selling Self-Regulatory Council (DSSRC) recommended that Lemongrass Spa Products modify or discontinue certain earnings and health-related product performance claims. 

Read the Decision Summary
Decision

National Advertising Division Recommends Blueprint Test Preparation Discontinue Certain MCAT Score Improvement Claims

New York, NY – April 22, 2024 – The National Advertising Division recommended Blueprint Test Preparation discontinue certain express and implied claims made in connection with its four MCAT preparation courses, including claims that Blueprint students raise their MCAT scores by 15 or 13 points on average.

Read the Decision Summary
Decision

National Advertising Division Recommends The Princeton Review Discontinue Point Increase Claims for MCAT Test Preparation Services

New York, NY – April 18, 2024 – In a Fast-Track SWIFT challenge, the National Advertising Division recommended that The Princeton Review (TPR) discontinue claims that its students “Score a 515+ on the MCAT or add 15 points depending on your starting score. Guaranteed or your money back.”

Read the Decision Summary
Decision

Direct Selling Self-Regulatory Council Recommends Trades of Hope Discontinue Salesforce Member Earnings Claims

McLean, VA – April 17, 2024 – The Direct Selling Self-Regulatory Council (DSSRC) recommended that Trades of Hope discontinue certain earnings claims made by salesforce members on Facebook and YouTube. 

Read the Decision Summary